27283081|t|Sinus augmentation using a histone deacetylase inhibitor in a calcium sulfate carrier in rabbit: A pilot study
27283081|a|Histone deacetylase inhibitors such as sodium butyrate (SB) have been suggested to be promising candidate small molecules for bone regeneration. In this study, the capacity of SB loaded onto calcium sulfate (CaS) to enhance bone formation was investigated in a rabbit sinus model. Following preparation of the sinus access window on a randomly selected side, SB loaded onto CaS (CaS / SB) was grafted in five rabbits, and CaS alone (control) was grafted in another five rabbits. The animals were euthanized after 4 weeks for radiographic, histometric, and immunohistochemical analyses. There was a statistically significant difference in the total augmented volume between the groups in the radiographic analysis (158.22 ± 39.31 mm(3) and 107.09 ± 39.69 mm(3), respectively, p = 0.040). The CaS / SB group showed a larger portion of mature lamellar bone and a higher level of mineralization of bone trabeculae, characterized by more intense labeling with osteocalcin compared with the control group in the immunohistochemical analysis. The number of osteocalcin-positive cells within the central area of the augmented sinus was significantly higher in the CaS / SB group than in the control group (179 ± 26.0 mm(2) and 123 ± 33.2 mm(2), respectively, p = 0.027). In conclusion, CaS / SB exhibited superior osteogenic potential, especially in the central portion of the augmented sinus as well as improvement of the volume maintenance for sinus augmentation. © 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2016.
27283081	0	18	Sinus augmentation	T061	C2236586
27283081	27	56	histone deacetylase inhibitor	T116,T121,T126	C1512474
27283081	62	77	calcium sulfate	T121,T122,T197	C0006720
27283081	78	85	carrier	T122	C0013161
27283081	89	95	rabbit	T015	C3887509
27283081	99	110	pilot study	T062	C0031928
27283081	111	141	Histone deacetylase inhibitors	T116,T121,T126	C1512474
27283081	150	165	sodium butyrate	T109,T121	C0142812
27283081	167	169	SB	T109,T121	C0142812
27283081	207	232	candidate small molecules	T121	C1254351
27283081	237	254	bone regeneration	T042	C0005972
27283081	275	283	capacity	T081	C1516240
27283081	287	289	SB	T109,T121	C0142812
27283081	290	296	loaded	T052	C1708715
27283081	302	317	calcium sulfate	T121,T122,T197	C0006720
27283081	319	322	CaS	T121,T122,T197	C0006720
27283081	327	334	enhance	T052	C2349975
27283081	335	349	bone formation	T042	C0029433
27283081	372	390	rabbit sinus model	T008	C0599779
27283081	421	426	sinus	T030	C0030471
27283081	427	433	access	T169	C1554204
27283081	464	468	side	T082	C0441987
27283081	470	472	SB	T109,T121	C0142812
27283081	473	479	loaded	T052	C1708715
27283081	485	488	CaS	T121,T122,T197	C0006720
27283081	490	493	CaS	T121,T122,T197	C0006720
27283081	496	498	SB	T109,T121	C0142812
27283081	504	511	grafted	T061	C1961139
27283081	520	527	rabbits	T015	C3887509
27283081	533	536	CaS	T121,T122,T197	C0006720
27283081	544	551	control	T096	C0009932
27283081	557	564	grafted	T061	C1961139
27283081	581	588	rabbits	T015	C3887509
27283081	594	601	animals	T008	C0003062
27283081	607	617	euthanized	T058	C1136183
27283081	636	648	radiographic	T060	C1962945
27283081	650	661	histometric	T059	C0344441
27283081	667	686	immunohistochemical	T059	C1441616
27283081	687	695	analyses	T062	C0936012
27283081	709	734	statistically significant	T081	C0237881
27283081	759	768	augmented	T081	C0205217
27283081	769	775	volume	T082	C0456389
27283081	788	794	groups	T078	C0441833
27283081	802	823	radiographic analysis	T060	C1962945
27283081	902	905	CaS	T121,T122,T197	C0006720
27283081	908	910	SB	T109,T121	C0142812
27283081	911	916	group	T078	C0441833
27283081	926	932	larger	T081	C0549177
27283081	933	940	portion	T082	C0449719
27283081	944	950	mature	T079	C0205286
27283081	951	964	lamellar bone	T024	C0682560
27283081	987	1001	mineralization	T042	C2350989
27283081	1005	1020	bone trabeculae	T024	C2826619
27283081	1052	1060	labeling	T059	C0887853
27283081	1066	1077	osteocalcin	T116,T123	C0029419
27283081	1096	1109	control group	T096	C0009932
27283081	1117	1136	immunohistochemical	T059	C1441616
27283081	1137	1145	analysis	T062	C0936012
27283081	1161	1181	osteocalcin-positive	T116,T123	C0029419
27283081	1182	1187	cells	T025	C0007634
27283081	1199	1211	central area	T082	C0205099
27283081	1219	1228	augmented	T081	C0205217
27283081	1229	1234	sinus	T030	C0030471
27283081	1253	1259	higher	T080	C0205250
27283081	1267	1270	CaS	T121,T122,T197	C0006720
27283081	1273	1275	SB	T109,T121	C0142812
27283081	1276	1281	group	T078	C0441833
27283081	1294	1307	control group	T096	C0009932
27283081	1389	1392	CaS	T121,T122,T197	C0006720
27283081	1395	1397	SB	T109,T121	C0142812
27283081	1408	1416	superior	T080	C0205250
27283081	1417	1437	osteogenic potential	T042	C0029433
27283081	1457	1472	central portion	T082	C0449719
27283081	1480	1489	augmented	T081	C0205217
27283081	1490	1495	sinus	T030	C0030471
27283081	1507	1518	improvement	T077	C2986411
27283081	1526	1532	volume	T082	C0456389
27283081	1533	1544	maintenance	T052	C0024501
27283081	1549	1567	sinus augmentation	T061	C2236586